Chee Conley - Insider Non-Derivative Transactions at Syros Pharmaceuticals, Inc. (SYRS) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Sep 11, 2024, Chee Conley's relationship to Syros Pharmaceuticals, Inc. (SYRS) is Director,Officer (President & CEO), and currently has 122,504 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other SYRS insiders.
Data Source: SEC.
Chee Conley - Insider Non-Derivative Transactions of SYRS Common Stock
Chee Conley - Insider Non-Derivative Transactions at SYRS
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Sep 12, 2024 | P -- (Common Stock) | 50000 | 1.71 | 122504 |
| Sep 11, 2024 | P -- (Common Stock) | 50000 | 1.51 | 72504 |
| Apr 2, 2024 | F -- (Common Stock) | 3500 | 5.12 | 22504 |
| Apr 1, 2024 | M -- (Common Stock) | 2000 | 0 | 14338 |
| Apr 1, 2024 | M -- (Common Stock) | 11666 | 0 | 26004 |
| Nov 2, 2023 | F -- (Common Stock) | 6004 | 2.22 | 12338 |
| Nov 1, 2023 | M -- (Common Stock) | 17000 | 0 | 18342 |
| Apr 4, 2023 | F -- (Common Stock) | 658 | 2.58 | 1342 |
| Apr 1, 2023 | M -- (Common Stock) | 2000 | 0 | 2000 |